STRATEGIC GROUP THEORY: REVIEW‚ EXAMINATION AND APPLICATION IN THE UK PHARMACEUTICAL INDUSTRY by Graham Leask & David Parker Graham Leask‚ Aston Business School‚ Aston University‚ Birmingham B4 7ET‚ UK and David Parker‚ Cranfield School of Management‚ Cranfield University‚ Bedfordshire MK43 0AL‚ UK ACKNOWLEDGMENT The authors would like to acknowledge the valuable assistance of IMS Health in the preparation of this manuscript‚ in particular the assistance of Alan Johnson‚ and the helpful
Premium Strategic management Management
National Institute of Business Management Ist Floor‚ Swathandrya Samara Smrithi Bhavan‚ Nandavanam Road Palayam P.O. Trivandrum – 695 033 E-mail: admin@nibmglobal.com 0471- 4014294‚ 4014298 Assignments of One Year MBA / Two Year MBA/ One Year Executive MBA Semester - I 1. Students are requested to go through the instructions carefully. 2. The Assignment is a part of the internal assessment. 3. Marks will be awarded for each Assignment‚ which will be added to the total marks. Assignments
Premium Human resource management Management Human resources
Analysis of Indian Pharmaceutical Industry Dr. Reddy Laboratories Table of Contents Acknowledgement 4 1. Industry Analysis 5 1.1 Porter’s Five Forces Analysis 5 2. DRL’s Present Strategy 6 2.1Riding on Generics 6 2.2Focusing on depth rather than breadth 7 2.3 Leveraging strategic partnerships to reduce risk and investment 8 2.4 Para IV filings 9 2.5 Focusing on selected therapeutic areas 9 3. Key Issues faced by DRL 10 3.1 Poor positioning in India 10 3.2 Russian Opportunity
Premium Generic drug Pharmaceutical industry
SQUARE PHARMACEUTICALS LIMITED Mission Our Mission is to produce and provide quality & innovative healthcare relief for people‚ maintain stringently ethical standard in business operation also ensuring benefit to the shareholders‚ stakeholders and the society at large. Vision We view business as a means to the material and social wellbeing of the investors‚ employees and the society at large‚ leading to accretion of wealth through financial and moral gains as a part of the process of the
Premium Inventory Financial ratio Financial ratios
Big‚ Bad Pharma: An Unnecessary Evil Big‚ Bad Pharma: An Unnecessary Evil Big Pharma‚ or the pharmaceutical industry’s giant corporations‚ have earned record profits‚ falsified clinical trial data and corrupted the healthcare industry according to many industry critics including a recent report posted on Globalresearch.ca.[1] The industry’s story parallels the history of other corporate monopolies such as Big Oil‚ the Railroad Industry‚ Big Agriculture‚ banking interests and other industrial giants
Premium Pharmacology Clinical trial Medicine
Segmentation * Key Players in Pharma Industry * Market Drivers * Challenges for Pharma Industry * SWOT Analysis * References Introduction Indian Pharmaceutical Industry is one of the success stories of modern India. The wide ranging capabilities in the complex field of drug manufacture & technology has established India as one of the major producer of the Pharmaceuticals worldwide. De-licensing of the pharmaceutical industry gave freedom to Indian Pharma manufacturers to produce
Premium Pharmacology Pharmaceutical industry Generic drug
ratios for 5 pharmaceutical companies’ vis-à-vis the industry average for these ratios. 1. Debt-Equity ratio‚ 2. Current ratio‚ and 3. Interest coverage ratio The 5 companies analysed include: 1. Vivimed Labs 2. Anuh Pharma 3. Tonira Pharma 4. Lincoln Pharmaceuticals 5. Dishman Pharmaceuticals & Chemicals FACTS AND ASSUMPTIONS: As for the industry averages and industry best ratios‚ we have taken the BSE Healthcare index‚ and treated it as a representative of
Premium Pharmaceutical industry Pharmacology Pharmacy
CHAPTER: 1 INTRODUCTION History of Indian Pharma Industry The Pharmaceutical industry in India is the world ’s third-largest in terms of volume and stands 14th in terms of value. According to Department of Pharmaceuticals‚ Ministry of Chemicals and Fertilizers‚ the total turnover of India ’s pharmaceuticals industry between 2008 and September 2009 was US$21.04 billion. While the domestic market was worth US$ 12.26 billion. Sale of all types of medicines in the country is expected to
Premium Pharmaceutical industry Pharmacology Generic drug
Table of Contents CHAPTER 01: COMPANY OVERVIEW 1.1 Introduction The flagship company of the Square group of industries‚ Square Pharmaceuticals Limited (SPL) is the largest pharmaceuticals company in Bangladesh. Founded in 1958 and headquartered in Dhaka‚ Bangladesh‚ SPL develops‚ manufactures and markets drugs for humans and the animal world. The company owns and operates modern pharmaceutical factories mainly in Bangladesh and also has a separate division to operate a modern chemical
Premium Pharmaceutical industry Pharmacology
evade taxes by any chance v. Profit flies back to the home country 3. Define Subsidiary A unit plant or factory plant of the MNC that is usually located in LEDCs where costs are low (such as wages‚ land). 4. Why did N-Pharma open subsidiaries in Australia‚ Canada‚ Mexico‚ Chile‚ Vietnam‚ South Korea and New Zealand? i. Expansion for markets and proximity to the market ii. Vietnam‚
Premium Marketing Cash flow Stock market